Literature DB >> 9781914

Klippel-Trenaunay syndrome.

S A Berry1, C Peterson, W Mize, K Bloom, C Zachary, P Blasco, D Hunter.   

Abstract

Patients with Klippel-Trenaunay (KT) syndrome have a complex constellation of anomalies that includes cutaneous capillary malformation (usually on an affected limb), abnormal development of the deep and superficial veins, and limb asymmetry, usually enlargement. Mixed vascular malformations may be present and include capillary, venous, arterial, and lymphatic systems. The records of 79 patients referred for vascular anomalies were reviewed and 49 were found to have the three "cardinal" anomalies of KT syndrome. Twenty-six females and 23 males had 46 affected legs (27 right legs), 23 affected arms (15 right), 21 affected trunks, and 10 affected heads. Thirty-six had only one affected quadrant, 8 had two, and 5 had three or more. Although 40 patients had increased limb girth, measurable length discrepancy was noted in only 17 individuals. Patients were evaluated using a noninvasive imaging strategy including color duplex ultrasonography, MRI, lymphoscintigraphy, and plain radiographs. Treatment included compression, pulsed-dye laser treatment, reduction of arteriovenous malformations, and orthopedic procedures for overgrowth. All KT cases in this series occurred sporadically. We speculate that KT syndromes may be due to a somatic mutation for a factor critical to vasculogenesis and angiogenesis in embryonic development.

Entities:  

Mesh:

Year:  1998        PMID: 9781914

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  28 in total

Review 1.  Venous malformation: update on aetiopathogenesis, diagnosis and management.

Authors:  A Dompmartin; M Vikkula; L M Boon
Journal:  Phlebology       Date:  2010-10       Impact factor: 1.740

Review 2.  Hemimegalencephaly: clinical implications and surgical treatment.

Authors:  C Di Rocco; D Battaglia; D Pietrini; M Piastra; L Massimi
Journal:  Childs Nerv Syst       Date:  2006-07-05       Impact factor: 1.475

3.  [Klippel-Trénaunay syndrome. A rare cause of recurrent macrohematuria: case report].

Authors:  L Rinnab; T Paiss; R Küfer
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

4.  Klippel-Trenaunay Syndrome: a case report with brief review of literature.

Authors:  Mohammad Iqbal Zea; Mohammad Hanif; Mohammad Habib; Ahmed Ansari
Journal:  J Dermatol Case Rep       Date:  2009-12-30

Review 5.  Pelvic vascular malformations.

Authors:  Brian M Christenson; Matthew G Gipson; Mitchell T Smith
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

6.  Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin.

Authors:  Teng Zhang; Yufeng Yao; Jingjing Wang; Yong Li; Ping He; Vinay Pasupuleti; Zhengkun Hu; Xinzhen Jia; Qixue Song; Xiao-Li Tian; Changqing Hu; Qiuyun Chen; Qing Kenneth Wang
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

7.  Identification of association of common AGGF1 variants with susceptibility for Klippel-Trenaunay syndrome using the structure association program.

Authors:  Y Hu; L Li; S B Seidelmann; A A Timur; P H Shen; D J Driscoll; Q K Wang
Journal:  Ann Hum Genet       Date:  2008-06-16       Impact factor: 1.670

8.  [Klippel-Trenaunay-Weber syndrome].

Authors:  Murat Ugurlucan; Can Yerebakan; Ufuk Alpagut; Emin Tireli; Enver Dayioglu
Journal:  Wien Med Wochenschr       Date:  2008

9.  Dominant inheritance and intra-familial variations in the association of Sturge-Weber and Klippel-Trenaunay-Weber syndromes.

Authors:  José Maria Pereira de Godoy; Agnes Cristina Fett-Conte
Journal:  Indian J Hum Genet       Date:  2010-01

10.  Epithelioid Angiosarcoma in a Patient with Klippel-Trénaunay-Weber Syndrome: An Unexpected Response to Therapy.

Authors:  Angela Simas; Catarina Matos; Rodrigo Lopes da Silva; Vítor Brotas; Eugénio Teófilo; José Pereira Albino
Journal:  Case Rep Oncol       Date:  2010-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.